Synovus Announces Results of Exchange Offer
|
|
|
| Posted
:
Tue, 03 Nov 2009 14:10:13 GMT |
| Author
:
Synovus Financial Corp.
|
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
| Press Release
News |
Home
|
|
|
|
COLUMBUS, Ga. - (Business Wire) Synovus Financial Corp. (NYSE: SNV) (the “Company”) today announced the results of its previously announced offer to exchange (the “Exchange Offer”) up to 50 million newly issued shares of the Company’s common stock for any and all of its outstanding 4.875% Subordinated Notes Due 2013 (the “Notes”). According to information provided by the exchange agent for the Exchange Offer, BNY Mellon Shareowner Services, approximately $29,820,000 in aggregate principal amount of the Notes, representing approximately 12.6% of the $236,570,000 aggregate principal amount of the Notes outstanding prior to the Exchange Offer, has been validly tendered and not withdrawn in the Exchange Offer. The Company has accepted all of the Notes validly tendered and not withdrawn and, pursuant to the terms of the Exchange Offer, will issue approximately 9.44 million shares of the Company's common stock as consideration for the Notes. Following the settlement of the Exchange Offer, approximately $206,750,000 in aggregate principal amount of the Notes will remain outstanding. The Exchange Offer expired at 11:59 P.M. (New York City time) on November 2, 2009. The Company expects the settlement of the Exchange Offer to occur on November 5, 2009. J.P. Morgan Securities Inc. acted as the Company’s sole financial advisor in connection with the Exchange Offer. J.P. Morgan Securities Inc. was not retained to, and did not, solicit acceptances of the Exchange Offer or make any recommendations to holders with respect thereto. About Synovus Synovus is a financial services holding company with approximately $35 billion in assets based in Columbus, Georgia. Synovus provides commercial and retail banking, as well as investment services, to customers through 30 banks, 328 offices, and 463 ATMs in Georgia, Alabama, South Carolina, Florida and Tennessee. The company focuses on its unique decentralized customer delivery model, position in high-growth Southeast markets and commitment to being a great place to work to ensure unparalleled customer experiences. See Synovus on the Web at www.synovus.com. Synovus Financial Corp. Patrick A. Reynolds, 706-649-4973 Director of Investor Relations
|

Copyright © 2008
Business Wire. All rights reserved.
|
|
|
|
|
Related
News
GoldenSource Market Leadership Recognised in Financial News Tech21 List
LONDON, November 23 /PRNewswire/ -- GoldenSource has been recognised as a
leading innovator in financial markets technology by Financial News in its
4th annual Tech 21 list of innovators and market leaders for the 21st century.
GoldenSource wa...
Advanced ID Corp. Completes Repayment of La Jolla Cove Funding CALGARY, AB -- 11/23/09 --
Advanced ID Corporation (OTCBB: AIDO) a
leading developer of RFID solutions for supply chain applications, fleet
operations, animal tracking and tire management announces today that it has
fulfilled the terms of the Sept..
Research and Markets: 2009 Plimsoll Analysis - Abnormal Load Haulage - a Comprehensive Profile of 80 Companies Operating in the UK Market DUBLIN -
Research and Markets (
Aesthetic Plastic Surgery: The Next Generation Symposium Launches in NYC NEW YORK -
Aesthetic Plastic Surgery: The Next Generation Symposium will be held
from December 4-6 at the Waldorf Astoria, announces Z. Paul Lorenc, MD,
FACS, New York aesthetic plastic surgeon and Chairman of the APSSNY.
The CME-accredited three-day interactive conference, h
MedPro Safety Products Reports Recent Progress LEXINGTON, Ky. -
MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development
and marketing of passive needlestick injury prevention technology, today
reported on the Company’s recent progress.
The recent highlights include:
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
NOVATO, Calif., Nov. 23 -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP) today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist...
AngioDynamics to Participate in the 21st Annual Piper Jaffray Health Care Conference QUEENSBURY, N.Y. -
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the 21st
Annual Piper Jaffray Health Care Conference in New York
|
|
|
|
|
|
|
|
|